{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T23:08:54Z","timestamp":1792451334638,"version":"4.5.0"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,21]],"date-time":"2022-10-21T00:00:00Z","timestamp":1666310400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100005595","name":"University of California","doi-asserted-by":"publisher","award":["C21CR2150"],"award-info":[{"award-number":["C21CR2150"]}],"id":[{"id":"10.13039\/100005595","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmn.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Opinion in Chemical Biology"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.cbpa.2022.102229","type":"journal-article","created":{"date-parts":[[2022,11,19]],"date-time":"2022-11-19T11:56:46Z","timestamp":1668859006000},"page":"102229","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["Realgar and arsenene nanomaterials as arsenic-based anticancer agents"],"prefix":"10.1016","volume":"72","author":[{"given":"Sophia E.","family":"Hollow","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3615-4530","authenticated-orcid":false,"given":"Timothy C.","family":"Johnstone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cbpa.2022.102229_bib1","first-page":"1","article-title":"Arsenic-based drugs: from Fowler's solution to modern anticancer chemotherapy","volume":"32","author":"Gibaud","year":"2010"},{"key":"10.1016\/j.cbpa.2022.102229_sref2","article-title":"Arsenic in medicine: past, present and future","author":"Paul","year":"2022","journal-title":"Biometals"},{"key":"10.1016\/j.cbpa.2022.102229_bib3","first-page":"14","article-title":"The drugs of sleeping sickness: their mechanisms of action and resistance, and a brief history","volume":"5","author":"De Koning","year":"2020","journal-title":"Trav Med Infect Dis"},{"key":"10.1016\/j.cbpa.2022.102229_bib4","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.envint.2014.10.022","article-title":"Organoarsenicals in poultry litter: detection, fate, and toxicity","volume":"75","author":"Mangalgiri","year":"2015","journal-title":"Environ Int"},{"key":"10.1016\/j.cbpa.2022.102229_bib5","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1258\/jrsm.2009.09k036","article-title":"The introduction of \u2018chemotherapy\u2019 using arsphenamine \u2013 the first magic bullet","volume":"102","author":"Williams","year":"2009","journal-title":"J\u00a0R Soc Med"},{"key":"10.1016\/j.cbpa.2022.102229_bib6","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1093\/annonc\/mdj019","article-title":"Treatment of acute promyelocytic leukemia with arsenic trioxide without ATRA and\/or chemotherapy","volume":"17","author":"Ghavamzadeh","year":"2006","journal-title":"Ann Oncol"},{"key":"10.1016\/j.cbpa.2022.102229_bib7","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1056\/NEJMoa1300874","article-title":"Retinoic acid and arsenic trioxide for acute promyelocytic leukemia","volume":"369","author":"Lo-Coco","year":"2013","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cbpa.2022.102229_bib8","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1016\/S1470-2045(15)00193-X","article-title":"Arsenic trioxide and all-trans retinoic acid treatment for acute promyelocytic leukaemia in all risk groups (AML17): results of a randomised, controlled, phase 3 trial","volume":"16","author":"Burnett","year":"2015","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.cbpa.2022.102229_bib9","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/j.1365-2141.2009.07623.x","article-title":"Notoriety to respectability: a short history of arsenic prior to its present day use in haematology","volume":"145","author":"Doyle","year":"2009","journal-title":"Br J Haematol"},{"key":"10.1016\/j.cbpa.2022.102229_bib10","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s00775-018-1537-9","article-title":"Arsenic trioxide: insights into its evolution to an anticancer agent","volume":"23","author":"Hoonjan","year":"2018","journal-title":"J\u00a0Biol Inorg Chem"},{"key":"10.1016\/j.cbpa.2022.102229_bib11","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1002\/med.21844","article-title":"Current status and future prospects of nanomedicine for arsenic trioxide delivery to solid tumors","volume":"42","author":"S\u00f6nksen","year":"2021","journal-title":"Med Res Rev"},{"key":"10.1016\/j.cbpa.2022.102229_bib12","doi-asserted-by":"crossref","first-page":"743","DOI":"10.3390\/pharmaceutics14040743","article-title":"Current advances of nanomedicines delivering arsenic trioxide for enhanced tumor therapy","volume":"14","author":"Yu","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.cbpa.2022.102229_bib13","doi-asserted-by":"crossref","first-page":"12292","DOI":"10.1021\/ic401211u","article-title":"Anticancer activity of small-molecule and nanoparticulate arsenic(III) complexes","volume":"52","author":"Swindell","year":"2013","journal-title":"Inorg Chem"},{"key":"10.1016\/j.cbpa.2022.102229_bib14","doi-asserted-by":"crossref","first-page":"4826","DOI":"10.1073\/pnas.0712365105","article-title":"Dissection of mechanisms of Chinese medicinal formula Realgar-Indigo naturalis as an effective treatment for promyelocytic leukemia","volume":"105","author":"Wang","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.cbpa.2022.102229_bib15","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1007\/s11655-011-0894-9","article-title":"Clinical observation of the treatment of myelodysplastic syndrome mainly with Qinghuang Powder (\u9752\u9ec4\u6563)","volume":"17","author":"Xu","year":"2011","journal-title":"Chin J Integr Med"},{"key":"10.1016\/j.cbpa.2022.102229_bib16","article-title":"Oral arsenic-containing Qinghuang powder (\u9752\u9ec4\u6563): a potential drug for myelodysplastic syndromes","author":"Ming","year":"2020","journal-title":"Chin J Integr Med"},{"key":"10.1016\/j.cbpa.2022.102229_bib17","doi-asserted-by":"crossref","first-page":"55","DOI":"10.2147\/CMAR.S280886","article-title":"Clinical response to traditional Chinese herbs containing realgar (As2S2) is related to DNA methylation patterns in bone marrow DNA from patients with myelodysplastic syndrome with multilineage dysplasia","volume":"13","author":"Zhou","year":"2021","journal-title":"Cancer Manag Res"},{"key":"10.1016\/j.cbpa.2022.102229_bib18","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.597601","article-title":"Oral realgar-indigo naturalis formula plus retinoic acid for acute promyelocytic leukemia","volume":"10","author":"Lou","year":"2021","journal-title":"Front Oncol"},{"key":"10.1016\/j.cbpa.2022.102229_sref19","first-page":"179","article-title":"Chinese guidelines for diagnosis and treatment of acute promyelocytic leukemia (2018)] (\u4e2d\u56fd\u6025\u6027\u65e9\u5e7c\u7c92\u7ec6\u80de\u767d\u8840\u75c5\u8bca\u7597\u6307\u5357(2018 \u5e74\u7248","volume":"39","year":"2018","journal-title":"Zhonghua Xue Ye Xue Za Zhi"},{"key":"10.1016\/j.cbpa.2022.102229_bib20","first-page":"154","article-title":"Safety and efficacy of Compound Huangdai Tablets combined with all-trans retinoic acid for treatment of acute promyelocytic leukemia: clinical evidence and potential mechanisms","volume":"14","author":"Huang","year":"2022","journal-title":"Chin. Herb. Med."},{"key":"10.1016\/j.cbpa.2022.102229_bib21","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s00280-022-04449-9","article-title":"The comparison of plasma arsenic concentration and urinary arsenic excretion during treatment with Realgar-Indigo naturalis formula and arsenic trioxide in children with acute promyelocytic leukemia","volume":"90","author":"Liao","year":"2022","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.cbpa.2022.102229_bib22","doi-asserted-by":"crossref","first-page":"11596","DOI":"10.1021\/ja804436w","article-title":"Arsenic(II) sulfide quantum dots prepared by a wet process from its bulk","volume":"130","author":"Wang","year":"2008","journal-title":"J\u00a0Am Chem Soc"},{"key":"10.1016\/j.cbpa.2022.102229_bib23","doi-asserted-by":"crossref","first-page":"6282","DOI":"10.1002\/anie.200900586","article-title":"Fluorescent nanogel of arsenic sulfide nanoclusters","volume":"48","author":"Wang","year":"2009","journal-title":"Angew Chem, Int Ed"},{"key":"10.1016\/j.cbpa.2022.102229_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.gene.2021.145666","article-title":"Nano-realgar suppresses lung cancer stem cell growth by repressing metabolic reprogramming","volume":"788","author":"Yang","year":"2021","journal-title":"Gene"},{"key":"10.1016\/j.cbpa.2022.102229_bib25","doi-asserted-by":"crossref","first-page":"148","DOI":"10.2174\/1567201817666200115105633","article-title":"Realgar nanoparticles inhibit migration, invasion and metastasis in a mouse model of breast cancer by suppressing matrix metalloproteinases and angiogenesis","volume":"17","author":"Xiaoxia","year":"2020","journal-title":"Curr Drug Deliv"},{"key":"10.1016\/j.cbpa.2022.102229_sref26","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1007\/s11596-022-2605-5","article-title":"Acid water-ground nano-realgar is superior to crude realgar in promoting apoptosis of MCF-7 breast cancer cells","volume":"42","author":"Xi","year":"2022","journal-title":"Curr Med Sci"},{"key":"10.1016\/j.cbpa.2022.102229_bib27","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.9754","article-title":"Involvement of autophagy in realgar quantum dots (RQDs) inhibition of human endometrial cancer JEC cells","volume":"8","author":"Liu","year":"2020","journal-title":"PeerJ"},{"key":"10.1016\/j.cbpa.2022.102229_bib28","doi-asserted-by":"crossref","first-page":"6485","DOI":"10.1021\/acsanm.2c00577","article-title":"Fluorescent realgar nanoclusters for nuclear targeting-triggered tumor theranostics","volume":"5","author":"Shi","year":"2022","journal-title":"ACS Appl Nano Mater"},{"key":"10.1016\/j.cbpa.2022.102229_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2020.119616","article-title":"Temperature-sensitive gel-loaded composite nanomedicines for the treatment of cervical cancer by vaginal delivery","volume":"586","author":"Zhang","year":"2020","journal-title":"Int J Pharm"},{"key":"10.1016\/j.cbpa.2022.102229_bib30","article-title":"Recent advances in arsenene nanostructures towards prediction, properties, synthesis and applications","volume":"28","author":"Bhuvaneswari","year":"2022","journal-title":"Surface Interfac"},{"key":"10.1016\/j.cbpa.2022.102229_sref31","doi-asserted-by":"crossref","first-page":"5151","DOI":"10.1002\/anie.201913675","article-title":"Arsenene: a potential therapeutic agent for acute promyelocytic leukaemia cells by acting on nuclear proteins","volume":"59","author":"Wang","year":"2020","journal-title":"Angew Chem, Int Ed"},{"key":"10.1016\/j.cbpa.2022.102229_bib32","article-title":"Arsenene nanomotors as anticancer drug carrier","volume":"21","author":"Rosli","year":"2020","journal-title":"Appl Mater Today"},{"key":"10.1016\/j.cbpa.2022.102229_bib33","doi-asserted-by":"crossref","first-page":"2216","DOI":"10.1039\/D0MH01992E","article-title":"PSMA-targeted arsenic nanosheets: a platform for prostate cancer therapy via ferroptosis and ATM deficiency-triggered chemosensitization","volume":"8","author":"Wang","year":"2021","journal-title":"Mater Horiz"},{"key":"10.1016\/j.cbpa.2022.102229_bib34","doi-asserted-by":"crossref","first-page":"45137","DOI":"10.1021\/acsami.2c10743","article-title":"Multi-omics analysis reveals the unexpected immune regulatory effects of arsenene nanosheets in tumor microenvironment","volume":"14","author":"Wang","year":"2022","journal-title":"ACS Appl Mater Interfaces"},{"key":"10.1016\/j.cbpa.2022.102229_bib35","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202170292","article-title":"Arsenene nanodots with selective killing effects and their low-dose combination with \u00df-elemene for cancer therapy","volume":"33","author":"Liu","year":"2021","journal-title":"Adv Mater"},{"key":"10.1016\/j.cbpa.2022.102229_sref36","doi-asserted-by":"crossref","first-page":"4777","DOI":"10.1038\/s41467-021-24961-5","article-title":"Arsenene-mediated multiple independently targeted reactive oxygen species burst for cancer therapy","volume":"12","author":"Kong","year":"2021","journal-title":"Nat Commun"}],"container-title":["Current Opinion in Chemical Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1367593122001144?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1367593122001144?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T02:49:25Z","timestamp":1761274165000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1367593122001144"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":36,"alternative-id":["S1367593122001144"],"URL":"https:\/\/doi.org\/10.1016\/j.cbpa.2022.102229","relation":{},"ISSN":["1367-5931"],"issn-type":[{"value":"1367-5931","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Realgar and arsenene nanomaterials as arsenic-based anticancer agents","name":"articletitle","label":"Article Title"},{"value":"Current Opinion in Chemical Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cbpa.2022.102229","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"102229"}}